Counteracting Alzheimer's disease via normalizing neurovascular unit with a self-regulated multi-functional nano-modulator

IF 14.6 1区 医学 Q1 PHARMACOLOGY & PHARMACY Acta Pharmaceutica Sinica. B Pub Date : 2024-12-01 Epub Date: 2024-05-22 DOI:10.1016/j.apsb.2024.05.017
Xue Xia , Ya Wei , Qianqian Huang , Yang Zhou , Xiaorong Wang , Yulong Shi , Xiaotong Yang , Wenqin Yang , Yiwei Zhang , Ting Lei , Yuan Huang , Hanmei Li , Meng Qin , Huile Gao
{"title":"Counteracting Alzheimer's disease via normalizing neurovascular unit with a self-regulated multi-functional nano-modulator","authors":"Xue Xia ,&nbsp;Ya Wei ,&nbsp;Qianqian Huang ,&nbsp;Yang Zhou ,&nbsp;Xiaorong Wang ,&nbsp;Yulong Shi ,&nbsp;Xiaotong Yang ,&nbsp;Wenqin Yang ,&nbsp;Yiwei Zhang ,&nbsp;Ting Lei ,&nbsp;Yuan Huang ,&nbsp;Hanmei Li ,&nbsp;Meng Qin ,&nbsp;Huile Gao","doi":"10.1016/j.apsb.2024.05.017","DOIUrl":null,"url":null,"abstract":"<div><div>The neurovascular unit (NVU) is highly responsible for cerebral homeostasis and its dysfunction emerges as a critical contributor to Alzheimer's disease (AD) pathology. Hence, rescuing NVU dysfunction might be a viable approach to AD treatments. Here, we fabricated a self-regulated muti-functional nano-modulator (siR/PIO@RP) that can intelligently navigate to damaged blood-brain barrier and release therapeutical cargoes for synergetic AD therapy. The resulting siR/PIO@RP enables self-regulation of its distribution in accordance with the physio/pathological state (low/high RAGE expression) of the target site <em>via</em> a feedback loop. siR/PIO@RP is capable of performing intricate tasks and goes beyond the capabilities of single-target therapeutic agents utilized in AD therapy, such as reducing cerebral A<em>β</em> load, relieving neuroinflammation, and alleviating the dysfunction of NVU. Overall, the current study provides proof of concept that normalizing NVU holds promise as a means of alleviating AD symptoms.</div></div>","PeriodicalId":6906,"journal":{"name":"Acta Pharmaceutica Sinica. B","volume":"14 12","pages":"Pages 5464-5478"},"PeriodicalIF":14.6000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Pharmaceutica Sinica. B","FirstCategoryId":"92","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2211383524001941","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/5/22 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

The neurovascular unit (NVU) is highly responsible for cerebral homeostasis and its dysfunction emerges as a critical contributor to Alzheimer's disease (AD) pathology. Hence, rescuing NVU dysfunction might be a viable approach to AD treatments. Here, we fabricated a self-regulated muti-functional nano-modulator (siR/PIO@RP) that can intelligently navigate to damaged blood-brain barrier and release therapeutical cargoes for synergetic AD therapy. The resulting siR/PIO@RP enables self-regulation of its distribution in accordance with the physio/pathological state (low/high RAGE expression) of the target site via a feedback loop. siR/PIO@RP is capable of performing intricate tasks and goes beyond the capabilities of single-target therapeutic agents utilized in AD therapy, such as reducing cerebral Aβ load, relieving neuroinflammation, and alleviating the dysfunction of NVU. Overall, the current study provides proof of concept that normalizing NVU holds promise as a means of alleviating AD symptoms.

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
通过自调节多功能纳米调节器使神经血管正常化来对抗阿尔茨海默病
神经血管单元(NVU)高度负责大脑内稳态,其功能障碍是阿尔茨海默病(AD)病理的关键因素。因此,挽救NVU功能障碍可能是治疗AD的可行方法。在这里,我们制造了一种自我调节的多功能纳米调节剂(siR/PIO@RP),它可以智能地导航到受损的血脑屏障并释放治疗货物,用于协同治疗AD。由此产生的siR/PIO@RP能够通过反馈回路根据靶点的生理/病理状态(低/高RAGE表达)自我调节其分布。siR/PIO@RP能够执行复杂的任务,并且超越了AD治疗中使用的单靶点治疗药物的能力,例如减少脑Aβ负荷,缓解神经炎症和减轻NVU功能障碍。总的来说,目前的研究证明了正常化NVU作为缓解AD症状的一种手段是有希望的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Acta Pharmaceutica Sinica. B
Acta Pharmaceutica Sinica. B Pharmacology, Toxicology and Pharmaceutics-General Pharmacology, Toxicology and Pharmaceutics
CiteScore
22.40
自引率
5.50%
发文量
1051
审稿时长
19 weeks
期刊介绍: The Journal of the Institute of Materia Medica, Chinese Academy of Medical Sciences, and the Chinese Pharmaceutical Association oversees the peer review process for Acta Pharmaceutica Sinica. B (APSB). Published monthly in English, APSB is dedicated to disseminating significant original research articles, rapid communications, and high-quality reviews that highlight recent advances across various pharmaceutical sciences domains. These encompass pharmacology, pharmaceutics, medicinal chemistry, natural products, pharmacognosy, pharmaceutical analysis, and pharmacokinetics. A part of the Acta Pharmaceutica Sinica series, established in 1953 and indexed in prominent databases like Chemical Abstracts, Index Medicus, SciFinder Scholar, Biological Abstracts, International Pharmaceutical Abstracts, Cambridge Scientific Abstracts, and Current Bibliography on Science and Technology, APSB is sponsored by the Institute of Materia Medica, Chinese Academy of Medical Sciences, and the Chinese Pharmaceutical Association. Its production and hosting are facilitated by Elsevier B.V. This collaborative effort ensures APSB's commitment to delivering valuable contributions to the pharmaceutical sciences community.
期刊最新文献
Biomimetic liposomes synergize with high-intensity focused ultrasound to induce ferroptosis in tumors Table of Contents Artificial intelligence-guided design of lipid nanoparticles for mRNA delivery Biomimetic nitric oxide nanogenerators for synergistic gas-mild photothermal therapy of large solid tumor Harnessing deep learning to accelerate the development of antibodies and aptamers
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1